Jessica Federer

Ms. Federer is an investor, board member, and a globally recognized leader in digital transformation, health technologies, and women's health. She is the Managing Director for The Women's Health Fund. Previously, she was the Chief Digital Officer for one of the world’s largest life sciences companies, leading the enterprise-wide digital transformation for Bayer A.G. across the Pharmaceutical, Consumer Care, Crop Science, and Animal Health businesses. She was the first woman to hold this role in the pharma industry globally. She is an external senior advisor for McKinsey and has advised both Fortune Global 100 companies and industry disrupting start-ups. During the pandemic, she joined Europe’s fastest growing digital health company as Managing Director, building a U.S. team and expanding into decentralized clinical trials for international Covid-19 vaccine studies. Federer also serves on the board of Angelini Ventures, a Rome-based fund investing in biotech and digital health, and was previously a partner at an established Boston based VC. She founded the Health of Women Investor Summit, convening investors representing trillions in investment capital, and serves on both the Yale Ventures Blavatnik Advisor board and the Yale Institutional Review Board. Federer was on the United Nations International Telecommunications Union m-powering development advisory board and the BHP Science and Innovation Advisory Council. She is recognized as a 2023 “Icon” by Rock Health, a Health Equity Champion, and one of the top 100 CDOs. Federer began her public health career at the Agency for Healthcare Research and Quality in the US Department of Health and Human Services. She earned a Bachelor of Science from the George Washington University, and a Master of Public Health from Yale.

Liz Powell    

Esq., MPH, Founder & CEO

G2G & Women's Health Advocates

Liz is the Founder of G2G Consulting, which creates and implements policy, funding and advocacy Government to Growth (G2G) strategies for clients—securing $612 million in funding since 2007. She has served on the Steering Committee for the Innovation Equity Forum (IEF) led by the NIH Office of Research on Women's Health and the Bill and Melinda Gates Foundation since 2023 and created the Women’s Health Advocates in 2025 and the Breast Cancer Early Detection Coalition in 2024. Previously, she served as Legislative Director in Congress where she staffed the Congressional Caucus for Women’s Issues, Armed Services Committee and Small Business Committee. Liz also was a Policy Analyst for the UK Parliament’s Health Committee and worked on congressional and presidential political campaigns. Awarded the Woman Entrepreneur of the Year and Women of Achievement awards, Liz also authored “Gaming the System” on the legal barriers to accessing medicines and earned her MPH from Harvard, JD from George Washington, and BA from Colgate.